Literature DB >> 27459916

A case of acute encephalopathy with biphasic seizures and late reduced diffusion: Utility of arterial spin labeling sequence.

Keita Kuya1, Shinya Fujii2, Fuminori Miyoshi2, Koyo Ohno3, Yuki Shinohara2, Yoshihiro Maegaki3, Toshihide Ogawa2.   

Abstract

A 1-year-old boy was admitted because of febrile status epilepticus (FSE). A secondary cluster of seizures was seen on day 5 after onset, and the patient eventually displayed developmental delay. Conventional magnetic resonance imaging (MRI) showed no abnormal findings on day 1 after onset, but showed reduced diffusion in the subcortical regions of bilateral frontal lobes on day 5 after onset. Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) was diagnosed. Arterial spin labeling (ASL) revealed reduced cerebral blood flow (CBF) in bilateral frontal lobes on day 1 after onset and showed increased CBF in the corresponding region in the subacute phase. Outcomes after prolonged febrile seizures are usually good, but mental deficit and/or epilepsy often remain in AESD. Discriminating between these syndromes is difficult, because no useful biomarkers have been identified. Reduced CBF in bilateral frontal lobes was observed on ASL on day 1 of FSE in the present case, and this finding may be predictive of developing AESD.
Copyright © 2016 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute encephalopathy with biphasic seizures and late reduced diffusion; Arterial spin labeling sequence; Febrile status epilepticus; Magnetic resonance imaging

Mesh:

Year:  2016        PMID: 27459916     DOI: 10.1016/j.braindev.2016.07.003

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  1 in total

1.  Do lesional perfusion abnormalities on arterial spin labeling truly contribute to the diagnosis of Leigh syndrome?

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Pediatr Radiol       Date:  2016-11-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.